S100A10 and cancer: In cancer cells, increased annexin A2 and S100A10 expression result in increased plasmin production, which leads to the degradation of the ECM and activation of MMPs, thereby enabling the invasion of surrounding organs or local vasculature (Figure 2) [35,36,37].